Subcutaneous immunotherapy versus sublingual immunotherapy: Which is more effective?

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 2, 2014, Pages 144-149

  Nelson, Harold S ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Allergen extracts; Allergic asthma; Allergic rhinitis; Immunotherapy; Meta analysis; Subcutaneous; Sublingual

Indexed keywords

ALLERGEN; PLACEBO;

ALLERGIC RHINITIS; ASTHMA; COMPARATIVE EFFECTIVENESS; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG SAFETY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MEDICAL PRACTICE; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHINOCONJUNCTIVITIS; RISK BENEFIT ANALYSIS; STUDY DESIGN; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; SYSTEMATIC REVIEW (TOPIC); TREATMENT RESPONSE;

ALLERGEN EXTRACTS; ALLERGIC ASTHMA; ALLERGIC RHINITIS; IMMUNOTHERAPY; META-ANALYSIS; SUBCUTANEOUS; SUBLINGUAL;

ASTHMA; DESENSITIZATION, IMMUNOLOGIC; HUMANS; INJECTIONS, SUBCUTANEOUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHINITIS, ALLERGIC, PERENNIAL; SUBLINGUAL IMMUNOTHERAPY;

EID: 84895436294     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.11.018     Document Type: Article

References (47)

1. Calderon M.A., Alves B., Jacobson M., Hurwitz B., Sheikh A., Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007, (1):CD001936.
2. Radulovic S., Wilson D., Calderon M., Durham S. Systematic reviews of sublingual immunotherapy (SLIT). Allergy 2011, 66:740-752.
3. Abramson M.J., Puy R.M., Winer J.M. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010, (8):CD001186.
4. Calamita Z., Saconato H., Pela A.B., Atailah A.N. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy 2006, 61:1162-1172.
5. Marogna M., Tomassetti D., Bernasconi A., Colombo F., Massola A., Businco A.D., et al. Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. Ann Allergy Asthma Immunol 2008, 101:206-211.
6. Jacobsen L., Niggemann B., Dreborg S., Ferdousi H.A., Halken S., Host A., et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007, 62:943-948.
7. Marogna M., Spadolini I., Massolo A., Canonica G.W., Passalacqua G. Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. JAllergy Clin Immunol 2010, 126:969-975.
8. Pajno G.B., Barberio G., De Luca F., Morabito L., Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001, 31:1392-1397.
9. Durham S.R., Walker S.M., Varga E.M., Jacobson M.R., O'Brien F., Noble W., et al. Long-term clinical efficacy of grass-pollen immunotherapy. NEngl J Med 1999, 341:468-475.
10. Durham S.R., Emminger W., Kapp A., de Monchy J.G., Rak S., Scadding G.K., et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. JAllergy Clin Immunol 2012, 129:717-725.
11. Jutel M., Akdis M., Budak F., Aebischer-Casaulta C., Wrzyszcz M., Blaser K., et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003, 33:1205-1214.
12. Mobs C., Ipsen H., Mayer L., Slotosch C., Petersen A., Wurtzen P.A., et al. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, an synthesis of IgE-blocking antibodies. JAllergy Clin Immunol 2012, 130:1108-1116.
13. Bohle B., Kinaciyan T., Gerstmayr M., Radakovics A., Jahn-Schmid B., Ebner C. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. JAllergy Clin Immunol 2007, 120:707-713.
14. Hamid Q.A., Schotman E., Jacobson M.R., Walker S.M., Durham S.R. Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. JAllergy Clin Immunol 1997, 99:454-460.
15. Nelson H., Blaiss M., Nolte H., Wurtz S.O., Andersen J.S., Durham S.R. Efficacy and safety of the SQ-standardized grass allergy immunotherapy tablet in mono- and polysensitized subjects. Allergy 2012, 68:252-255.
16. Calderon M.A., Simons F.E.R., Malling H.J., Lockey R.F., Moingeon P., Demoly P. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile. Allergy 2012, 67:302-311.
17. Reid M.J., Lockey R.F., Turkeltaub P.C., Platts-Mills T.A. Survey of fatalities from skin testing and immunotherapy 1985-1989. JAllergy Clin Immunol 1993, 92:6-15.
18. Bernstein D.I., Wanner M., Borish L., Liss G.M. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. JAllergy Clin Immunol 2004, 113:1129-1136.
19. Epstein T.G., Liss G.M., Murphy-Berendts K., Bernstein D.I. AAAAI and ACAAI surveillance study of subcutaneous immunotherapy. Year 3: what practices modify the risk of systemic reactions?. Ann Allergy Asthma Immunol 2013, 110:274-278.
20. Nelson H.S. Subcutaneous injection immunotherapy for optimal effectiveness. Immunol Allergy Clin North Am 2011, 31:211-226.
21. Durham S.R., Yang W.H., Pedersen M.R., Johansen N., Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. JAllergy Clin Immunol 2006, 117:802-809.
22. Didier A., Malling H.J., Worm M., Horak F., Jager S., Montagut A., et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. JAllergy Clin Immunol 2007, 120:1338-1345.
23. Cox L., Larenas Linnemann D., Nolte H., Weldon D., Finegold I., Nelson H.S. Sublingual immunotherapy: a comprehensive review. JAllergy Clin Immunol 2006, 117:1021-1035.
24. Marogna M., Spadolini I., Massolo A., Canonica G.W., Passalacqua G. Clinical, function, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized study. JAllergy Clin Immunol 2005, 115:1184-1188.
25. Novembre E., Galli E., Landi F., Caffarelli C., Pifferi M., De Marco E., et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. JAllergy Clin Immunol 2004, 114:851-857.
26. Lowell F.C., Franklin W. A double-blind study of the effectiveness and specificity of injection therapy in ragweed hay fever. N Engl J Med 1965, 273:675.
27. Johnstone D.E., Dutton A. The value of hyposensitization therapy for bronchial asthma in children: A 14-year study. Pediatrics 1968, 42:793-802.
28. Nelson H.S. Multiallergen immunotherapy for allergic rhinitis and asthma. JAllergy Clin Immunol 2009, 123:763-769.
29. Swamy R.S., Reshamwala N., Hunter T., Vissamsetti S., Santos C.B., Baroody F.M., et al. Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy. JAllergy Clin Immunol 2012, 130:215-224.
30. Marogna M., Spadolini I., Massolo A., Zanon P., Berra D., Chiodini E., et al. Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients. Ann Allergy Asthma Immunol 2007, 98:274-280.
31. Amar S.M., Harbeck R.J., Sills M., Silveira L.J., O'Brien H., Nelson H.S. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract. JAllergy Clin Immunol 2009, 124:150-156.
32. Calderon M.A., Boyle R.J., Penagos M., Sheikh A. Immunotherapy: The Meta-analyses. What have we learned?. Immunol Allergy Clin N Am 2011, 31:159-173.
33. Chelladurai Y., Suarez-Cuervo C., Erekosima N., Kim J.M., Ramanathan M., Segal J.B., et al. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. J Allergy Clin Immunol Pract 2013, 1:361-369.
34. Eifan A.O., Akkoc T., Yildiz A., Keles S., Ozdemir C., Bahceciler N.N., et al. Clinical efficacy and immunological mechanism of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial. Clin Exp Allergy 2010, 40:922-932.
35. Mungan D., Misirligil Z., Gurbuz L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma-a placebo controlled study. Ann Allergy Asthma Immunol 1999, 82:485-490.
36. Yukselen A., Kendirli S.G., Yilmax M., Altintas D.U., Karakoc G.B. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study. Int Arch Allergy Immunol 2012, 157:288-298.
37. Keles S., Karakoc-Aydiner E., Ozen A., Izgi A.G., Tevetoglu A., Akkoc T., et al. Anovel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes. JAllergy Clin Immunol 2011, 128:808-815.
38. Khinchi M.S., Poulsen L.K., Carat F., Andre C., Hansen A.B., Malling H.J. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004, 59:45-53.
39. Tahamiler R., Saritzali G., Canakcioglu S., Ozcora E. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis. ORL J Otorhinolaryngol Relat Spec 2008, 70:144-150.
40. Mauroa M., Russelloa M., Incorvaiab C., Gazzolaa G.B., Di Carac G., Frati F. Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study. Eur Ann Allergy Clin Immunol 2007, 39:119-122.
41. Piazza I., Bizzaro N. Humoral response to subcutaneous, oral, and nasal immunotherapy of allergic rhinitis due to Dermatophagoides pteronyssinus. Ann Allergy 1993, 71:461-469.
42. Dretzke J., Meadows A., Novielli N., Huisson A., Fry-Smith A., Meads C. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison. JAllergy Clin Immunol 2013, 131:1361-1366.
43. Quirino T., Iemoli E., Siciliani E., Parmiani S., Milazzo F. Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study. Clin Exp Allergy 1996, 26:1253-1261.
44. Ventura M.T., Carretta A., Tummolo R.A., Buquicchio R., Arsdieni A., Murgia N. Clinical data and inflammation parameters in patient with cypress allergy treated with sublingual swallow therapy and subcutaneous immunotherapy. Int J Immunopathol Pharmacol 2009, 22:403-413.
45. Antunez C., Mayorga C., Corzo J.K., Jurado A., Torres M.J. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration. Pediatr Allergy Immunol 2007, 19:210-218.
46. Creticos P.S., Maloney J., Bernstein D.I., Casale T., Kaur A., Fisher R., et al. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults. JAllergy Clin Immunol 2013, 131:1342-1349.
47. Nolte H., Hebert J., Berman G., Gawchik S., White M., Kaur A., et al. Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults. Ann Allergy Asthma Immunol 2013, 110:450-456.